10 years ago, Matthew Gfeller died from a high school football injury. His family honors his life by pushing for research into brain trauma

Wake Forest School of Medicine graduate student Mireille Kelley shows the impact sensors in a football helmet that transmit information to a laptop computer in a protective case for use on a football sideline.

From athlete to researcher: Flood, a former Wake Forest football player, is studying concussions

Will Flood is currently pursuing his doctorate in Neuroscience at Wake Forest School of Medicine. Since 2015 as an undergrad, he’s worked with Dr. Joel Stitzel and the joint Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences using his knowledge of football to research concussions and CTE – a disease plaguing the game he once played. 

Scientists Identify Genetic Marker for Gastric Cancer Prognosis

“Immunotherapy treatment has shown remarkable benefit for some cancer patients whereas others experience toxicities,” said Wei Zhang, Ph.D., professor of cancer biology at Wake Forest Baptist and lead author of the study. “More potential markers are urgently needed to help oncologists decide which patient would benefit from this promising new treatment strategy.”

H-DAPPs nanoparticles show ability to locate and treat breast tumors

Researchers have developed a fluorescing nanoparticle capable of finding tumours, lighting up upon arrival and being activated with light to generate heat to destroy the cancer cells…  “An unexpected result was how efficiently the nanoparticles localised to the tumours without any targeting agent,” said the study’s lead author, Dr. Nicole Levi-Polyachenko, Associate Professor of Plastic and Reconstructive surgery at Wake Forest School of Medicine. 

Read the news release.

Scientists use nanotechnology to detect molecular biomarker for osteoarthritis

Adam Hall, assistant professor of biomedical engineering at Wake Forest School of Medicine, injects microliters of fluid into a flow cell holding a nanopore device that has demonstrated the ability to detect molecular biomarkers of disease.

Read the news release. 

Body-On-A-Chip System Could Lead to New Drug Candidates

“There is an urgent need for improved systems to accurately predict the effects of drugs, chemicals and biological agents on the human body,” said Dr. Anthony Atala, director of the institute and senior researcher on the multi-institution body on a chip project, funded by the Defense Threat Reduction Agency, said in a statement.

Read the news release.